| 1991 |
Targeted disruption of Hox-1.6 (Hoxa1) in mice causes defects in rhombomeres 4-7, including absence of cranial nerves and ganglia, and malformed inner ears and skull bones, demonstrating Hoxa1 is required for regional specification along the rostrocaudal axis in its most rostral domain of expression. |
Homologous recombination gene targeting in embryonic stem cells, mouse knockout |
Cell |
High |
1346922 1680563
|
| 1992 |
A retinoic acid-responsive enhancer located 3' of the Hoxa1 gene (containing a RARE identical to that of RARbeta) is required for retinoic acid-induced transcriptional activation of Hoxa1; the RARE alone is insufficient and other sequences within the enhancer also contribute. |
DNase I hypersensitivity mapping, lacZ minigene reporter assays in transgenic mice, F9 teratocarcinoma cell transfection |
Mechanisms of development |
High |
1360810
|
| 1995 |
An evolutionarily conserved enhancer within the Hoxa1 locus containing a retinoic acid response element drives expression in neuroepithelium caudal to rhombomere 4; point mutations in the RARE abolish this expression, supporting a direct role for endogenous retinoids in Hoxa1 regulation and hindbrain patterning. |
Transgenic mouse reporter assays with RARE point mutations |
Development (Cambridge, England) |
High |
7743939
|
| 1998 |
HOXA1 and HOXB1, together with cofactor PBX1, bind to Hox-Pbx consensus sites in the EphA2 enhancer and transcriptionally activate EphA2 expression; this is required for rhombomere 4-specific EphA2 expression in vivo, as EphA2 expression is reduced in Hoxa1/Hoxb1 double mutants. |
In vitro DNA binding (EMSA/co-immunoprecipitation), co-transfection reporter assays, transgenic embryo analysis, double-mutant mice |
The Journal of biological chemistry |
High |
9733765
|
| 1998 |
Hoxa1 and Hoxb1 genetically synergize to pattern the hindbrain, cranial nerves, and second pharyngeal arch; double null mutants show loss of all second arch-derived elements and complete disruption of ear development, phenotypes not seen in single mutants. |
Genetic epistasis via compound double-mutant mice, neurofilament staining, retrograde motor neuron labeling |
Development (Cambridge, England) |
High |
9463349 9463359
|
| 1998 |
Hoxa1 is the primary mediator of the retinoic acid response of the Hoxb1 autoregulatory enhancer (b1-ARE) in vivo; this function requires binding of SOX/OCT heterodimers to the b1-ARE. HOXA1 has significantly lower transcriptional activity than HOXB1 from the b1-ARE, with the differential activity mapped to the HOXB1 N-terminal transcriptional activation domain. |
Transgenic mice, cell transfection reporter assays, SOX/OCT site mutagenesis, analysis of Hoxa1 mutant mice |
The Journal of biological chemistry |
High |
11278854
|
| 1998 |
Hoxa1 is required to set the anterior limit of Hoxb1 expression at the r3/r4 boundary; loss of Hoxa1 initiates a cascade of gene misexpressions causing misspecification of hindbrain compartments r2 through r5, followed by ectopic apoptosis. |
Genetic epistasis via single and double knockout mice, molecular marker analysis |
Development (Cambridge, England) |
High |
10662633
|
| 1998 |
The YPWM motif of HOXA1 is strictly required for cooperative DNA binding with PBX cofactors in vitro and in vivo; the YPWM motif contacts the PBX homeodomain. The GKFQ domain of PBX increases DNA binding by PBX but is not a primary contact site for HOXA1's YPWM motif. |
In vitro DNA binding assays (EMSA), co-transfection, deletion/mutagenesis of E2A-PBX |
The Journal of biological chemistry |
High |
9582372
|
| 1999 |
Hoxa1 and Hoxb1 double mutants show loss of both rhombomeres 4 and 5 and selective loss of the second branchial arch, demonstrating overlapping functions in rhombomere identity specification; the aberrant hindbrain subsequently undergoes size regulation through apoptosis. |
Double knockout mice, molecular marker analysis, histology |
Development (Cambridge, England) |
High |
10529420
|
| 2001 |
Hoxa1 synergizes with Hoxb1 to generate cranial neural crest cells from r4; loss of both genes in the neuroepithelium reduces r4 size and abolishes its ability to generate neural crest cells in a cell-autonomous manner. |
Ectoderm-specific double-mutant mice, molecular and lineage analysis, grafting experiments in cultured embryos |
Development (Cambridge, England) |
High |
11532923
|
| 2001 |
Ectopic neuronal groups established by misspecification in Hoxa1 null mice (from the r3-r4 level, including r2-identity progenitors) form a supernumerary functional neuronal circuit that integrates the respiratory rhythm-generating network at birth. |
Hoxa1 null mouse analysis, electrophysiology, neuroanatomical tracing |
The Journal of neuroscience |
Medium |
11466434
|
| 2002 |
HOXA1 is functionally interchangeable with HOXB1 when protein-coding sequences are swapped at the respective loci in mice, demonstrating that subfunctionalization of Hox1 paralogs is mediated primarily by divergence of transcriptional regulatory elements rather than protein sequence differences. |
Knock-in mouse lines with swapped coding regions, insertion of Hoxb1 autoregulatory enhancer into Hoxa1 locus |
Developmental cell |
High |
16890163
|
| 2002 |
Hoxa1 homeodomain residues 2 and 3 (asparagine and alanine, unusual compared to typical basic residues) function as specificity determinants when Hoxa1 acts as a monomer, but do not influence target specificity in Pbx1a-Hoxa1 heterodimers in vitro; however, on the Hoxb1 autoregulatory enhancer these residues can modulate Hoxa1 activity even in the presence of Pbx, in a cell-type-dependent manner. |
Site-directed mutagenesis, cell transfection reporter assays, in vitro DNA binding |
Nucleic acids research |
Medium |
12060683
|
| 2002 |
Forced HOXA1 expression in human mammary carcinoma cells upregulates Bcl-2 transcription, promotes cell survival, anchorage-independent growth, and oncogenic transformation of immortalized mammary epithelial cells with in vivo tumor formation. |
Forced expression in human mammary cells, soft agar colony formation, in vivo tumor formation, Bcl-2 reporter assays |
The Journal of biological chemistry |
Medium |
12482855
|
| 2005 |
E-cadherin-mediated cell-cell contact increases HOXA1 expression in mammary carcinoma cells through Rac1 signaling; HOXA1 is required downstream of E-cadherin for anchorage-independent proliferation and survival. |
E-cadherin blocking antibody, EGTA treatment, calcium rescue, Rac1 inhibition, HOXA1 siRNA knockdown |
The Journal of biological chemistry |
Medium |
16373333
|
| 2007 |
HOXA1-mediated oncogenic transformation of mammary epithelial cells requires activation of the p44/42 MAP kinase pathway; HOXA1 transcriptionally upregulates GRB2 and MEK1 and increases ERK phosphorylation, and MEK1 inhibition blocks HOXA1-driven proliferation, survival, and transformation. |
Microarray gene expression profiling, forced expression/depletion of HOXA1, MEK1 inhibitor treatment, Western blot |
Oncogene |
Medium |
17213808
|
| 2007 |
Polycomb group protein SUZ12 associates with the Hoxa1 RARE prior to retinoic acid treatment; RA treatment attenuates SUZ12 association and decreases H3K27me3 at the Hoxa1 RARE, while increasing H3ac, H3K4me2, and RNA Pol II occupancy. RAR-gamma and RXR-alpha are present at the RARE before and during RA treatment. |
Chromatin immunoprecipitation (ChIP) in F9 embryonal carcinoma cells |
Journal of molecular biology |
Medium |
17663992
|
| 2008 |
Hoxa1 is required for retinoic acid-induced neuronal differentiation of embryonic stem cells; Hoxa1 null ES cells fail to express neuronal markers and instead upregulate endodermal markers (Sox17); re-introduction of Hoxa1 rescues neuronal differentiation. Hoxa1 may promote neural differentiation by inhibiting Sox17 expression. |
Hoxa1 null ES cells, RA-induced differentiation protocol, marker expression analysis, Hoxa1 rescue by metallothionein-driven re-expression |
Journal of neuroscience research |
Medium |
18512762
|
| 2010 |
Hoxa1 lineage tracing using Hoxa1-IRES-Cre mice reveals that Hoxa1-expressing precursors contribute directly to the otic epithelium (except sensory patches), atria and outflow tract of the developing heart, and rhombomere 3—demonstrating broader direct roles for Hoxa1 than previously recognized. |
Cre-mediated lineage tracing (Hoxa1-IRES-Cre), reporter gene activation in mouse embryos |
Developmental biology |
High |
20171203
|
| 2011 |
Hoxa1 null mice display cardiovascular defects including interrupted aortic arch, aberrant subclavian artery, and Tetralogy of Fallot; Hoxa1 is expressed in precursors of cardiac neural crest cells and acts upstream of genes controlling neural crest specification, indicating Hoxa1 regulates heart development via cardiac NCCs. |
Hoxa1 null mice, cardiac morphology analysis, gene expression analysis of NCC specification markers |
Human molecular genetics |
High |
21940751
|
| 2011 |
Histone demethylase KDM3A (JMJD1A) activates HOXA1 transcription by demethylating H3K9me2 at the HOXA1 promoter; KDM3A knockdown reduces HOXA1 and CCND1 levels causing G1 arrest, and KDM3A expression positively correlates with HOXA1 in cancer cell lines. |
siRNA knockdown of KDM3A, ChIP showing KDM3A binding to HOXA1 promoter, H3K9me2 demethylation assay, cell cycle analysis |
International journal of cancer |
Medium |
22020899
|
| 2011 |
Microarray analysis of Hoxa1 null embryos identified downstream targets of Hoxa1 including Zic1, Hnf1b, Foxd3 (neural crest induction), Pax8 and Fgfr3 (inner ear), and Lhx5 (brainstem neurons), placing Hoxa1 upstream of these genes in a developmental genetic cascade. |
Microarray on microdissected Hoxa1 null vs. wild-type embryo tissue, gene expression validation |
Developmental biology |
Medium |
21784065
|
| 2012 |
Hoxa1 interacts with a broad network of proteins including components of cell-signaling transduction, cell adhesion, and vesicular trafficking, as identified by a systematic yeast two-hybrid screen against ~12,200 ORFs; 45 interactions confirmed by affinity co-purification, and 41 by Bimolecular Fluorescence Complementation revealing distinct intracellular localization patterns (vesicular, cytoplasmic, and nuclear compartments). |
Yeast two-hybrid screen, affinity co-purification in animal cell lines, Bimolecular Fluorescence Complementation |
BMC developmental biology |
Medium |
23088713
|
| 2013 |
The lncRNA linc-HOXA1, located ~50 kb from the Hoxa gene cluster, represses Hoxa1 transcription in cis by recruiting the protein PURB as a transcriptional cofactor; single-cell transcript counting shows anti-correlated expression of linc-HOXA1 and Hoxa1, and knockdown of linc-HOXA1 at its transcription site increases Hoxa1 transcription on the same chromosome. Retinoic acid disrupts this repression. |
Single-cell transcript counting, RNA FISH, siRNA knockdown, cis-acting analysis by allele-specific manipulation |
Genes & development |
High |
23723417
|
| 2014 |
ACK1 tyrosine kinase phosphorylates the histone demethylase KDM3A at tyrosine 1114 in a heregulin-dependent manner, decreasing H3K9me2 deposition and thereby increasing HOXA1 transcription; inhibition of ACK1 restores H3K9me2 marks and suppresses HOXA1 expression, conferring tamoxifen resistance. |
In vitro kinase assay, phospho-site mutagenesis, ChIP for H3K9me2, small-molecule ACK1 inhibitors (AIM-100, Dasatinib), siRNA knockdown |
The Journal of biological chemistry |
High |
25148682
|
| 2015 |
YAP (Hippo pathway transcriptional coactivator) regulates Hoxa1 expression in oral and dental epithelial tissues; ChIP assay implicates TEAD transcription factors as mediators of YAP-driven Hoxa1 regulation, and sphere formation assays show Hoxa1 is functionally involved in YAP-regulated epithelial progenitor proliferation. |
RNA-Seq, in situ hybridization, ChIP (YAP/TEAD), sphere formation assay, Yap conditional knockout and transgenic mice |
Molecular and cellular biology |
Medium |
25691658
|
| 2015 |
Hoxa1 and Hoxb1 are expressed in a sub-population of second heart field progenitors contributing to the cardiac outflow tract; compound Hoxa1−/−; Hoxb1+/− embryos display outflow tract defects with premature SHF differentiation, demonstrating redundant roles for Hoxa1 and Hoxb1 in outflow tract development upstream of FGF/ERK and BMP/SMAD signaling. |
Compound mutant mice, SHF marker analysis, FGF/ERK and BMP/SMAD pathway analysis |
Developmental biology |
Medium |
26284287
|
| 2016 |
HOXA1 physically interacts with RBCK1/HOIL-1 and TRAF2 (TNFR-associated proteins) via its 11-His repeat and homeodomain, and activates NF-κB signaling upstream of IκB through a non-transcriptional mechanism; RBCK1 and TRAF2 influences on NF-κB are epistatic to HOXA1. NF-κB activation is required for HOXA1 oncogenic activity. |
Proteome-wide yeast two-hybrid, co-immunoprecipitation, reporter assays for NF-κB, domain deletion/mutagenesis, epistasis experiments |
Nucleic acids research |
High |
27382069
|
| 2017 |
Genome-wide Hoxa1 binding analysis in differentiating ES cells reveals that Hoxa1 is rapidly recruited to target sites co-occupied by Nanog; Hoxa1 binds regulatory regions of Nanog, and Nanog binds the 3' enhancer of Hoxa1, establishing direct cross-regulatory mutual repression between Hoxa1 and the core pluripotency network. Hoxa1 also binds regulatory regions of Sox2, Esrrb, and Myc. |
ChIP-seq, genome-wide occupancy mapping, expression analysis, retinoic acid-induced ES cell differentiation |
Proceedings of the National Academy of Sciences of the United States of America |
High |
28584089
|
| 2017 |
Genome-wide Hoxa1 binding in differentiating ES cells maps to enhancer regions co-occupied by Hox cofactors; Hoxa1 targets multiple components of major signaling pathways (Wnt, TGF-β, Hedgehog, Hippo) and genes involved in neural crest migration, inner ear development, and heart development; two enhancers in Dok5 and Wls1 were validated for neural expression in mouse and zebrafish. |
ChIP-seq, differential gene expression analysis in Hoxa1 gain- and loss-of-function mouse and zebrafish, transgenic reporter assays |
Developmental biology |
High |
28982536
|
| 2017 |
KDM3B binds retinoic acid response elements (but not the promoter) of HOXA1 and demethylates H3K9 at those sites to transcriptionally activate HOXA1; KDM3B knockdown increases H3K9me1 but decreases H3K9me2 at the RARE region of HOXA1. |
KDM3B overexpression and knockdown, ChIP for KDM3B binding and H3K9 methylation marks, microarray profiling |
Leukemia & lymphoma |
Medium |
28540746
|
| 2018 |
The lncRNA HOTAIRM1 activates HOXA1 transcription in GBM by sequestering histone methyltransferases G9a (H3K9me2) and EZH2 (H3K27me3) and DNA methyltransferases (DNMT1, DNMT3b) away from the HOXA1 gene TSS, causing histone and DNA demethylation at that locus. |
ChIP assay for histone marks, RNA-ChIP for HOTAIRM1-protein interactions, bisulfite sequencing PCR for DNA methylation, HOTAIRM1 knockdown |
Journal of experimental & clinical cancer research |
Medium |
30376874
|
| 2020 |
The lncRNA HOTAIRM1 prevents PRC2 complex (EZH2) from binding the HOXA1 promoter and depositing H3K27me3, thereby maintaining HOXA1 expression in tamoxifen-resistant breast cancer cells; HOTAIRM1 directly interacts with EZH2. |
RNA immunoprecipitation (RIP) for HOTAIRM1-EZH2 interaction, ChIP for H3K27me3 at HOXA1 promoter, HOTAIRM1 knockdown |
Journal of Cancer |
Medium |
32284737
|
| 2020 |
LncRNA HotairM1 recruits EZH2 and SUZ12 to the HOXA1 promoter, inducing H3K27 trimethylation and epigenetic silencing of HOXA1; silencing of HOXA1 subsequently induces H3K27 acetylation at the Nanog enhancer, upregulating Nanog expression and promoting cancer stem cell self-renewal in a reciprocal HOXA1-Nanog loop. |
ChIP for H3K27me3 and H3K27ac, EZH2/SUZ12 recruitment assay, HOXA1 knockdown, Nanog expression analysis |
Molecular therapy. Nucleic acids |
Medium |
33230449
|
| 1994 |
Hoxa1 homeodomain protein binds to a site approximately 60 bp upstream of the L1 neural cell adhesion molecule transcription start site, as demonstrated by in vitro DNA binding assays; this site is also recognized by Pax-6. |
In vitro DNA binding (gel shift/footprinting) |
DNA and cell biology |
Low |
7917011
|
| 2023 |
HOXA1 transcriptionally activates NF-κB RelA (p65) and KLF4 in vascular smooth muscle cells, promoting VSMC-to-macrophage-like phenotypic transformation; HOXA1 knockdown in ApoE−/− mice reduces atherosclerotic plaque formation and VSMC transdifferentiation. |
AAV1-shHOXA1 knockdown in ApoE−/− mice, in vitro VSMC model, Western blot, ChIP (implied by transcriptional activation claim) |
Molecular medicine (Cambridge, Mass.) |
Low |
37528397
|